Investor FAQs
Show All
Where is Quince Therapeutics’ corporate headquarters?
611 Gateway Blvd., Suite 273
South San Francisco, California 94080
Where is the company incorporated?
Quince Therapeutics is incorporated in Delaware.
What is Quince Therapeutics’ fiscal year?
The company’s fiscal year-end is December 31.
How is Quince Therapeutics’ stock traded?
The company’s common stock trades on the Nasdaq Global Markets under the symbol “QNCX.”
Does Quince Therapeutics pay dividends?
The company does not currently pay dividends.
Who is the transfer agent for Quince Therapeutics?
The company’s transfer agent is EQ Transfer Agent Services.
Whom do I contact with questions about my stock?
Investors may contact the company’s transfer agent to address questions regarding their stock, such as the transfer of stock, change of address on a shareholder account, or to replace lost stock certificates, through the following ways:
EQ Transfer Agent Services
Website: https://equiniti.com/us/ast-access/
Phone: (800) 937-5449 • (718) 921-8124
Mail: EQ • P.O. Box 500 • Newark, New Jersey 07101
Who is the auditor for Quince Therapeutics?
The company’s auditors is BDO USA, LLP.
Who is legal counsel for Quince Therapeutics?
Cooley LLP.
Where can I find out more about Quince Therapeutics?
More information about Quince Therapeutics’ science and pipeline can be found on the company’s website at www.quincetx.com.
Where can I get the latest corporate news releases and financial reports?
The latest corporate news releases and financial reports from Quince Therapeutics can be found on the Investor section of the company’s website.
How can I view documents Quince Therapeutics has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
You may visit the Investor section of Quince Therapeutics’ website and locate the company’s SEC filings under Financial Information.
Whom should I contact regarding investor inquiries?
You may make inquiries to ir@quincetx.com.